Purpose of Technology: The purpose of indwelling pleural catheters (IPCs) is to allow for the intermittent drainage of accumulated fluid from the lungs that can occur as a complication of advanced malignancy, causing dyspnea, cough, and/or chest pain that lead to a decreased quality of life (QOL) and reduced functional ability.

Controversy: The main controversy surrounding the use of IPCs are their effectiveness compared with pleurodesis. Pleurodesis offers a more rapid resolution of the malignant pleural effusion (MPE), but is a more invasive procedure that requires a longer hospital stay and has a higher chance of failure and need for repeat procedures. An IPC can be implanted on an outpatient basis and is less invasive.

Relevant Questions:

  • Do IPCs provide adequate symptom palliation and improve outcomes in patients with MPEs and how do they compare with other treatments?

  • Are IPCs safe, and what are any related complications?

  • Have definitive patient selection criteria been established for IPCs for the management of MPEs?

If you have a Hayes login, click here to view the full report on the Knowledge Center.